Peter C. Keng, Ph.D.

See information for Patients. Viewing information for Researchers.

Contact

University of Rochester
School of Medicine and Dentistry
601 Elmwood Ave, Box 704
Rochester, New York 14642

Current Appointments

Education
PhD Radiation Biology Colorado State University 1978
BS Biology Tunghai University 1968
Post-Doctoral Training & Residency
Tumor biology at the University of Rochester Cancer Center 1978 - 1979
Recent Journal Articles
Showing the 5 most recent journal articles. (153 available)
Zhang, H.; Hyrien, O.; Pandya, K.; Keng, PC.; and Chen, Y. "Tumor response kinetics after schedule-dependent Paclitaxel chemoradiation treatment for inoperable non-small cell lung cancer: a model for low-dose chemotherapy radiosensitization." J Thoracic Oncology (2008).
Vitiello, PF.; Staversky, RJ.; Keng, PC.; and O'Reilly, MA. "PUMA inactivation protects against oxidative stress through p21/Bcl-XL inhibition of Bax death." Biochem (2008).
Chen, Y.; Pandya, KJ.; Keng, PC.; Smudzin, T.; Anderson, J.; Qazi, R.; Smith, B.; Watson, TJ.; Johnston, DW.; Feins, RH. "Phase II study of one-cycle induction docetaxel/cisplatin with rhG-CSF and sensitizing docetaxel chemoradiation for stage III non-small cell lung cancer." J Thoracic Oncology (2008).
Yee, M.; Vitiello, PF.; Keng, PC.; Palis, J.; Panoskaltsis-Mortari, A.; Blazar, BR.; Finkelstein, JN.; and O'Reilly, MA. "Identification of label-retaining Type II cells with limited ability to undergo transdifferentiation." Am J Physiol (2008).
Sun W; Wang W; Kim J; Keng P; Yang S; Zhang H; Liu C; Okunieff P; Zhang L. "Anti-cancer effect of resveratrol is associated with induction of apoptosis via a mitochondrial pathway alignment." Advances in experimental medicine and biology. 2008; 614():179-86.